SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-588999
Filing Date
2016-05-12
Accepted
2016-05-12 16:50:12
Documents
4
Period of Report
2016-06-30
Effectiveness Date
2016-05-12

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d43706ddef14a.htm DEF 14A 614048
2 GRAPHIC g43706g07w92.jpg GRAPHIC 7597
3 GRAPHIC g43706g33m68.jpg GRAPHIC 9340
4 GRAPHIC g43706g53p64.jpg GRAPHIC 8465
  Complete submission text file 0001193125-16-588999.txt   650562
Mailing Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612
Business Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Filer) CIK: 0001103021 (see all company filings)

IRS No.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31361 | Film No.: 161644637
SIC: 2834 Pharmaceutical Preparations